跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Difflam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Difflam
Approved
STANDARD
Difflam
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
428d48e8594757f6
Company
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Type
Standard
Approval Details
Approval Id
428d48e8594757f6
Drug Approval Philippines Name
Difflam
Product Name
Difflam
Registration Number
DR-XY47156
Brand Name
Difflam
Generic Name
Benzydamine Hydrochloride + Cetylpyridinium Chloride
Dosage Form
Lozenge (Strawberry Flavor)
Dosage Strength
3mg/1.33mg
Manufacturer
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Importer
Metro Drug, Inc.
Issuance Date
29 January 2021
Expiry Date
29 January 2026
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
428d48e8594757f6
Type
Standard
Back to Philippines FDA Approvals